Re-Appointed Hancock Puts Shoulder Into UK Digital Health-Care Drive

The UK election result allowed newly-reinstalled prime minister Johnson to tinker with his cabinet. Surviving the small reshuffle was health secretary Matt Hancock, who wasted no time in setting out 2020 plans to support the digitally-enabled NHS of the future.

Matt Hancock

The UK Department of Health and Social Care (DHSC) plans to keep pushing NHS hospitals and trusts towards digital fluency, including those who have not been part of the Global Digital Exemplar (GDE) program and those who need more encouragement.

GDEs are the most-digitally advanced NHS trusts. They were announced in 2017 and were promised £200m ($264m) funding in 2018,...

More from United Kingdom

HealthAI: ‘Established Regulations Already Exist For Regulating AI In Healthcare Safely’

 

Paul Campbell, chief regulatory officer at HealthAI, emphasizes existing regulations for AI in healthcare should not be overlooked as new regulations are developed.

Thena Capital’s New Fund Up And Running With £1M Investment In Plexāā’s Breast Cancer Device

 

Thena Capital, the first UK-based early-stage specialist medtech firm, has made its first investment since closing its £50m fund. Medtech Insight spoke with general partner Pamela Walker Geddes to gain insight into Thena Capital’s investment strategy.

Milner Pitch Day: Multiomic Pathology, Microcancer Avatars And Cell Morphology Intelligence

 

The Milner Institute, the on-campus hub for start-up acceleration at Cambridge University, hosted its annual Pitch Day on July 1. Start-ups Panakeia, PathwayBio and Sentinal4D presented diagnostic technologies.

Questions Over UK Prevention Agenda Within NHS 10-Year Plan

 
• By 

The UK government’s blueprint to deliver an NHS "fit for the future" was released on July 3.

More from Europe

EUDAMED Notice Anticipated By September As Commission Optimizes Operations

 

The last steps are taking place leading to the launch of the EU’s medical device database, EUDAMED.

FDA Greenlights Expanded Use Of Boston Scientific’s Pulse Field Ablation System

 

A recent approval from the US FDA allowing Boston Scientific to broaden its labeling for its pulse field ablation system means more patients with one type of AFib will have access to a promising new treatment.

Commission Decision Launches Pediatric And Rare Disease Expert Group

 

A revised annex to the original decision also outlines expert remuneration limits and introduces further changes.